SCOPUS 정보 검색 플랫폼

Volumn 28, Issue 5, 2012, Pages 789-796

A novel approach to the evaluation of bleeding-related episodes in patients with chronic immune thrombocytopenia

(9) Weitz, Ilene a Sanz, Miguel A b Henry, David c Schipperus, Martin d Godeau, Bertrand e Northridge, Kelly f Gleeson, Michelle f Danese, Mark f Deuson, Robert g

a UNIVERSITY OF SOUTHERN CALIFORNIA (United States)

b HOSPITAL UNIVERSITARIO LA FE (Spain)

c Pennsylvania Oncology Hematology Associates (United States)

d HAGA HOSPITAL (Netherlands)

e HENRI MONDOR HOSPITAL (France)

f Outcomes Insights Inc (United States)

g AMGEN INC (United States)

Author keywords

Autoimmune; Bleeding related episodes; BRE; Hemorrhage; Immunoglobulins; ITP; Platelet count; Thrombocytopenia; Thrombopoietin mimetic

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN; PLACEBO; ROMIPLOSTIM;

ARTICLE; AUTOIMMUNE THROMBOCYTOPENIA; BLEEDING; BLEEDING RELATED EPISODE; CHRONIC DISEASE; CHRONIC IMMUNE THROMBOCYTOPENIA; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHASE 3 CLINICAL TRIAL; SPLENECTOMY; THROMBOCYTE COUNT;

CHRONIC DISEASE; HEMORRHAGE; HUMANS; PLATELET COUNT; RECEPTORS, FC; RECOMBINANT FUSION PROTEINS; SPLENECTOMY; THROMBOCYTOPENIA; THROMBOPOIETIN; TREATMENT OUTCOME;

EID: 84861175085 PISSN: 03007995 EISSN: 14734877 Source Type: Journal
DOI: 10.1185/03007995.2012.684046 Document Type: Article

Times cited : (9)

References (17)

1
- 73249121880
- Pathogenesis of chronic immune thrombocytopenia: Increased platelet destruction and/or decreased platelet production
- Nugent D, McMillan R, Nichol JL, et al. Pathogenesis of chronic immune thrombocytopenia: increased platelet destruction and/or decreased platelet production. Br J Haematol 2009;146:585-96
- (2009) Br J Haematol , vol.146 , pp. 585-96
- Nugent, D.¹ McMillan, R.² Nichol, J.L.³

2
- 8944225498
- Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the American Society of Hematology
- George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996;88:3-40 (Pubitemid 26230668)
- (1996) Blood , vol.88 , Issue.1 , pp. 3-40
- George, J.N.¹ Woolf, S.H.² Raskob, G.E.³ Wasser, J.S.⁴ Aledort, L.M.⁵ Ballem, P.J.⁶ Blanchette, V.S.⁷ Bussel, J.B.⁸ Cines, D.B.⁹ Kelton, J.G.¹⁰ Lichtin, A.E.¹¹ McMillan, R.¹² Okerbloom, J.A.¹³ Regan, D.H.¹⁴ Warrier, I.¹⁵

3
- 0034641010
- The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts
- Cohen YC, Djulbegovic B, Shamai-Lubovitz O, et al. The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts. Arch Intern Med 2000;160:1630-8 (Pubitemid 30367902)
- (2000) Archives of Internal Medicine , vol.160 , Issue.11 , pp. 1630-1638
- Cohen, Y.C.¹ Djuibegovic, B.² Shamai-Lubovitz, O.³ Mozes, B.⁴

4
- 34648836081
- Immune thrombocytopenic purpura in adults
- DOI 10.1097/MOH.0b013e3282b9748f, PII 0006275220070900000020
- Godeau B, Provan D, Bussel J. Immune thrombocytopenic purpura in adults. Curr Opin Hematol 2007;14:535-56 (Pubitemid 47457646)
- (2007) Current Opinion in Hematology , vol.14 , Issue.5 , pp. 535-556
- Godeau, B.¹ Provan, D.² Bussel, J.³

5
- 0033960225
- Treatment options for chronic idiopathic (immune) thrombocytopenic purpura
- George JN. Treatment options for chronic idiopathic (immune) thrombocytopenic purpura. Semin Hematol 2000;37(1 Suppl 1):31-4 (Pubitemid 30080237)
- (2000) Seminars in Hematology , vol.37 , Issue.1 SUPPL. 1 , pp. 31-34
- George, J.N.¹

6
- 23944470406
- o(D) immune globulin intravenous administration for immune thrombocytopenic purpura
- DOI 10.1182/blood-2004-11-4303
- Gaines AR. Disseminated intravascular coagulation associated with acute hemoglobinemia or hemoglobinuria following Rh(0)(D) immune globulin intravenous administration for immune thrombocytopenic purpura. Blood 2005;106:1532-7 (Pubitemid 41208562)
- (2005) Blood , vol.106 , Issue.5 , pp. 1532-1537
- Gaines, A.R.¹

7
- 7244258758
- Rapid irreversible encephalopathy associated with anti-D immune globulin treatment for idiopathic thrombocytopenic purpura
- DOI 10.1002/ajh.20189
- Christopher K, Horkan C, Barb IT, et al. Rapid irreversible encephalopathy associated with anti-D immune globulin treatment for idiopathic thrombocytopenic purpura. Am J Hematol 2004;77:299-302 (Pubitemid 39430711)
- (2004) American Journal of Hematology , vol.77 , Issue.3 , pp. 299-302
- Christopher, K.¹ Horkan, C.² Barb, I.T.³ Arbelaez, C.⁴ Hodgdon, T.A.⁵ Yodice, P.C.⁶

8
- 66549130454
- Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: A report of 57 cases from the Research on Adverse Drug Events and Reports project
- Carson KR, Evens AM, Richey EA, et al. Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood 2009;113:4834-40
- (2009) Blood , vol.113 , pp. 4834-40
- Carson, K.R.¹ Evens, A.M.² Richey, E.A.³

9
- 34249733156
- New thrombopoietic growth factors
- DOI 10.1182/blood-2006-10-019315
- Kuter DJ. New thrombopoietic growth factors. Blood 2007;109:4607-16 (Pubitemid 46827750)
- (2007) Blood , vol.109 , Issue.11 , pp. 4607-4616
- Kuter, D.J.¹

10
- 60249099882
- Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: A randomised, double-blind, placebo-controlled trial
- Bussel JB, Provan D, Shamsi T, et al. Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial. Lancet 2009;373:641-8
- (2009) Lancet , vol.373 , pp. 641-8
- Bussel, J.B.¹ Provan, D.² Shamsi, T.³

11
- 38649120593
- Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: A double-blind randomised controlled trial
- DOI 10.1016/S0140-6736(08)60203-2, PII S0140673608602032
- Kuter DJ, Bussel JB, Lyons RM, et al. Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Lancet 2008;371:395-403 (Pubitemid 351181334)
- (2008) The Lancet , vol.371 , Issue.9610 , pp. 395-403
- Kuter, D.J.¹ Bussel, J.B.² Lyons, R.M.³ Pullarkat, V.⁴ Gernsheimer, T.B.⁵ Senecal, F.M.⁶ Aledort, L.M.⁷ George, J.N.⁸ Kessler, C.M.⁹ Sanz, M.A.¹⁰ Liebman, H.A.¹¹ Slovick, F.T.¹² De Wolf, J.T.M.¹³ Bourgeois, E.¹⁴ Guthrie Jr., T.H.¹⁵ Newland, A.¹⁶ Wasser, J.S.¹⁷ Hamburg, S.I.¹⁸ Grande, C.¹⁹ Lefrere, F.²⁰ more..

12
- 67749110321
- Quantifying the reduction in immunoglobulin use over time in patients with chronic immune thrombocytopenic purpura receiving romiplostim (AMG 531)
- Pullarkat VA, Gernsheimer TB, Wasser JS, et al. Quantifying the reduction in immunoglobulin use over time in patients with chronic immune thrombocytopenic purpura receiving romiplostim (AMG 531). Am J Hematol 2009;84:538-40
- (2009) Am J Hematol , vol.84 , pp. 538-40
- Pullarkat, V.A.¹ Gernsheimer, T.B.² Wasser, J.S.³

13
- 0035010803
- Metastatic bone disease: Clinical features, pathophysiology and treatment strategies
- DOI 10.1053/ctrv.2000.0210
- Coleman RE. Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev 2001;27:165-76 (Pubitemid 32452017)
- (2001) Cancer Treatment Reviews , vol.27 , Issue.3 , pp. 165-176
- Coleman, R.E.¹

14
- 63849111465
- Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP
- Bussel JB, Kuter DJ, Pullarkat V, et al. Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP. Blood 2009;113:2161-71
- (2009) Blood , vol.113 , pp. 2161-71
- Bussel, J.B.¹ Kuter, D.J.² Pullarkat, V.³

15
- 64049085194
- Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: Report from an international working group
- Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 2009;113:2386-93
- (2009) Blood , vol.113 , pp. 2386-93
- Rodeghiero, F.¹ Stasi, R.² Gernsheimer, T.³

16
- 75649104701
- International consensus report on the investigation and management of primary immune thrombocytopenia
- Provan D, Stasi R, Newland AC, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2009;115:168-86
- (2009) Blood , vol.115 , pp. 168-86
- Provan, D.¹ Stasi, R.² Newland, A.C.³

17
- 77954471988
- Evaluation of bleeding and thrombotic events during long-term use of romiplostim in patients with chronic immune thrombocytopenia (ITP)
- Gernsheimer TB, George JN, Aledort LM, et al. Evaluation of bleeding and thrombotic events during long-term use of romiplostim in patients with chronic immune thrombocytopenia (ITP). J Thromb Haemost 2010;8:1372-82
- (2010) J Thromb Haemost , vol.8 , pp. 1372-82
- Gernsheimer, T.B.¹ George, J.N.² Aledort, L.M.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.